Detalles de la búsqueda
1.
[Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
; 40(4): 435-441, 2023 Apr 10.
Artículo
en Zh
| MEDLINE | ID: mdl-36972938
2.
[The Effect and Safety of Flumatinib in Patients with Chronic Myelogenous Leukemia Failed First-and Second-line Treatment].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 32(2): 370-375, 2024 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-38660838
3.
[Clinical Efficacy and Safety of Ixazomib-Containing Regimens in the Treatment of Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 32(2): 483-492, 2024 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-38660856
4.
[Efficacy and Safety of Decitabine Combined with Modified EIAG Regimen in the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(2): 338-343, 2023 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-37096503
5.
[Clinical Significance of RAS Gene Mutations in Patients with Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 30(5): 1391-1396, 2022 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-36208240
6.
High ROBO3 expression predicts poor survival in non-M3 acute myeloid leukemia.
Exp Biol Med (Maywood)
; 246(10): 1184-1197, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541130
7.
GRAIL inhibits the growth, migration and invasion of lung adenocarcinoma cells by modulating STAT3/C-MYC signaling pathways.
J BUON
; 26(2): 353-358, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076979
8.
[IDH1 Gene Mutation and Its Clinical Significance in patients with Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 23(5): 1252-7, 2015 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-26524018
9.
[The incidence of TET2 gene mutation and its clinical significance in acute myeloid leukemia patients].
Zhonghua Xue Ye Xue Za Zhi
; 32(5): 304-7, 2011 May.
Artículo
en Zh
| MEDLINE | ID: mdl-21729597
Resultados
1 -
9
de 9
1
Próxima >
>>